• Priedigkeit, N.*, Watters, R.J.*(Co-First Author), Lucas, P.C., Basudan, A., Bhargava, R., Horne, W., Kolls, J.K., Fang, Z., Rosenzweig, M.Q., Brufsky, A.M., et al. (2017). Exome-Capture RNA-Sequencing Of Decade-Old Breast Cancers And Matched Decalcified Bone Metastases Identifies Clinically Actionable Targets. BioRxiv.
• Watters, R.J., Hartmaier, R.J., Osmanbeyoglu, H.U., Gillihan, R.M., Rae, J.M., Liao, L., Chen, K., Li, W., Lu, X., and Oesterreich, S. (2017). Steroid receptor coactivator-1 can regulate osteoblastogenesis independently of estrogen. Mol Cell Endocrinol 448, 21–27.
• Priedigkeit, N., Hartmaier, R.J., Chen, Y., Vareslija, D., Basudan, A., Watters, R.J., Thomas, R., Leone, J.P., Lucas, P.C., Bhargava, R., et al. (2016). Intrinsic subtype switching and acquired ERBB2/HER2 amplifications and mutations in breast cancer brain metastases. JAMA Oncology.
• Wang, P., Bahreini, A., Gyanchandani, R., Lucas, P.C., Hartmaier, R.J., Watters, R.J., Jonnalagadda, A.R., Trejo Bittar, H.E., Berg, A., Hamilton, R.L., et al. (2016). Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients. Clin Cancer Res 22, 1130–1137.
• Watters, R.J., Fox, T.E., Tan, S.-F., Shanmugavelandy, S., Choby, J.E., Broeg, K., Liao, J., Kester, M., Cabot, M.C., Loughran, T.P., et al. (2013). Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia. Leuk Lymphoma 54, 1288–1296.
• Watters, R.J., Kester, M., Tran, M.A., Loughran, T.P., and Liu, X. (2012). Development and use of ceramide nanoliposomes in cancer. Meth Enzymol 508, 89–108.
• Watters, R.J., Benos, P.V., and Oesterreich, S. (2012). To bind or not to bind--FoxA1 determines estrogen receptor action in breast cancer progression. Breast Cancer Res 14, 312.

PubMed LInk